Specifications
Immunogen
The antiserum was produced against synthesized peptide derived from internal of human NDUC2.
Applications
Application Notes
IHC: 1:50-1:100
ELISA: 1:10000
Target
Alternative Names
NDUFC2; NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa; NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 (14.5kD, B14.5b); NADH dehydrogenase [ubiquinone] 1 subunit C2; B14.5b; complex I subunit B14.5b; HLC 1; human lung cancer oncogene 1; complex I-B14.5b; human lung cancer oncogene 1 protein; NADH-ubiquinone oxidoreductase subunit B14.5b; HLC-1; NADHDH2; CI-B14.5b;
Product Background
Pathway
Alzheimers disease, organism-specific biosystem; Alzheimers disease, conserved biosystem; Electron Transport Chain, organism-specific biosystem; Huntingtons disease, organism-specific biosystem; Huntingtons disease, conserved biosystem; Metabolic pathways, organism-specific biosystem; Metabolism, organism-specific biosystem;
Citations
Publication ()
Have you cited CABT-BL5240 in a publication?
Let us know and earn a reward for your research.